ADMA Biologics Inc. (NASDAQ: ADMA) flaunted slowness of -2.72% at $1.43, as the Stock market unbolted on January 04, 2022. During the day, the stock rose to $1.49 and sunk to $1.42 before settling in for the price of $1.47 at the close. Taking a more long-term approach, ADMA posted a 52-week range of $1.01-$3.11.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 42.50%. Meanwhile, its Annual Earning per share during the time was 12.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 1.00%. This publicly-traded company’s shares outstanding now amounts to $133.77 million, simultaneously with a float of $109.67 million. The organization now has a market capitalization sitting at $262.16 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3760, while the 200-day Moving Average is $1.5027.
If we measure the efficiency of the company that is accounted for 406 employees. It has generated 103,734 per worker during the last fiscal year. Meanwhile, its income per employee was -186,114. The stock had 5.05 Receivables turnover and 0.25 Total Asset turnover. For the Profitability, stocks gross margin was -46.87, operating margin was -153.75 and Pretax Margin of -179.41.
ADMA Biologics Inc. (ADMA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the ADMA Biologics Inc. industry. ADMA Biologics Inc.’s current insider ownership accounts for 1.90%, in contrast to 24.10% institutional ownership. According to the most recent insider trade that took place on Oct 25, this organization’s President and CEO bought 250,000 shares at the rate of 1.00, making the entire transaction reach 250,000 in total value, affecting insider ownership by 1,128,444. Preceding that transaction, on Oct 25, Company’s President and CEO bought 100,000 for 1.00, making the whole transaction’s value amount to 100,000. This particular insider is now the holder of 2,137,616 in total.
ADMA Biologics Inc. (ADMA) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2021, it has been observed that the corporation posted -$0.13 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.14) by $0.01. This company achieved a net margin of -179.41 while generating a return on equity of -132.38. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
ADMA Biologics Inc.’s EPS increase for this current 12-month fiscal period is 1.00% and is forecasted to reach -0.24 in the upcoming year.
ADMA Biologics Inc. (NASDAQ: ADMA) Trading Performance Indicators
Let’s observe the current performance indicators for ADMA Biologics Inc. (ADMA). It’s Quick Ratio in the last reported quarter now stands at 1.90. The Stock has managed to achieve an average true range (ATR) of 0.09. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.83.
In the same vein, ADMA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.64, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be -0.24 at the market close of one year from today.
Technical Analysis of ADMA Biologics Inc. (ADMA)
Now, what If we examine the latest scores posted by [ADMA Biologics Inc., ADMA]. During the last 5-days, its volume was better the volume of 1.7 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 92.42% While, its Average True Range was 0.0900.
Raw Stochastic average of ADMA Biologics Inc. (ADMA) in the period of the previous 100 days is set at 60.00%, which indicates a major fall in contrast to 81.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.59% that was higher than 62.35% volatility it exhibited in the past 100-days period.